Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation

Virology

Volumn 389, Issue 1-2, 2009, Pages 82-90

  Haugen, Thomas H ^a,b   Lace, Michael J ^a,b   Ishiji, Takaoki ^c   Sameshima, Atsushi ^d   Anson, James R ^a   Turek, Lubomir P ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

BPV replication; Early gene expression; Transcription; Transformation

Indexed keywords

GENE PRODUCT; MESSENGER RNA; TRANSCRIPTION FACTOR SP1; VIRUS DNA; VIRUS PROTEIN;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; CELL IMMORTALIZATION; CELL LINE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA FLANKING REGION; EMBRYO; EPITHELIUM CELL; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; VIRUS GENOME; VIRUS MUTANT; VIRUS REPLICATION; WILD TYPE;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; CATTLE; CATTLE DISEASES; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; NUCLEAR PROTEINS; PAPILLOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

BOVINAE; BOVINE PAPILLOMAVIRUS - 1; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PARVOVIRUS; MURINAE; PAPILLOMAVIRIDAE;

EID: 67349145932     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.04.002     Document Type: Article

References (59)

1. Ahola H., Stenlund A., Moreno Lopez J., and Pettersson U. Promoters and processing sites within the transforming region of bovine papillomavirus type 1. J. Virol. 61 (1987) 2240-2244
2. Baker C.C., and Howley P.M. Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J. 6 (1987) 1027-1035
3. Baker C.C., and Noe J.S. Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells. J. Virol. 63 (1989) 3529-3534
4. Bernard H.U., and Apt D. Transcriptional control and cell type specificity of HPV gene expression. Arch. Dermatol. 130 (1994) 210-215
5. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
6. Campo M.S., Spandidos D.A., Lang J., and Wilkie N.M. Transcriptional control signals in the genome of bovine papillomavirus type 1. Nature 303 (1983) 77-80
7. Chin M.T., Hirochika R., Hirochika H., Broker T.R., and Chow L.T. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies. J. Virol. 62 (1988) 2994-3002
8. Choe J., Vaillancourt P., Stenlund A., and Botchan M. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs. J. Virol. 63 (1989) 1743-1755
9. Cripe T.P., Haugen T.H., Turk J.P., Tabatabai F., Schmid P.G., Dürst M., Gissmann L., Roman A., and Turek L.P. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO J. 6 (1987) 3745-3753
10. Cripe T.P., Alderborn A., Anderson R.D., Parkkinen S., Bergman P., Haugen T.H., Pettersson U., and Turek L.P. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. New. Biol. 2 (1990) 450-463
11. DiMaio D. Transforming activity of bovine and human papillomaviruses in cultured cells. Adv. Cancer Res. 56 (1991) 133-159
12. Dvoretzky I., Shober R., Chattopadhyay S.K., and Lowy D.R. A quantitative in vitro focus assay for bovine papilloma virus. Virology 103 (1980) 369-375
13. Forsberg M., and Westin G. Enhancer activation by a single type of transcription factor shows cell type dependence. EMBO J. 10 (1991) 2543-2551
14. Gius D., Grossman S., Bedell M.A., and Laimins L.A. Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18. J. Virol. 62 (1988) 665-672
15. Gloss B., Bernard H.U., Seedorf K., and Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 6 (1987) 3735-3743
16. Haugen T.H., Cripe T.P., Ginder G.D., Karin M., and Turek L.P. Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene. EMBO J. 6 (1987) 145-152
17. Haugen T.H., Turek L.P., Mercurio F.M., Cripe T.P., Olson B.J., Anderson R.D., Seidl D., Karin M., and Schiller J. Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain. EMBO J. 7 (1988) 4245-4253
18. Imagawa M., Chiu R., and Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51 (1987) 251-260
19. Ishiji T., Lace M.J., Parkkinen S., Anderson R.D., Haugen T.H., Cripe T.P., Xiao J.H., Davidson I., Chambon P., and Turek L.P. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in human keratinocytes and cervical carcinoma cells. EMBO J. 11 (1992) 2271-2281
20. Jacquemin P., Hwang J.J., Martial J.A., Dolle P., and Davidson I. A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain. J. Biol. Chem. 271 (1996) 21775-21785
21. Lace M.J., Anson J.R., Thomas G.S., Turek L.P., and Haugen T.H. The E8^E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J. Virol. 82 21 (2008) 10841-10853
22. Lace M.J., Anson J.R., Turek L.P., and Haugen T.H. Functional mapping of the human papillomavirus type 16 E1 cistron. J. Virol. 82 21 (2008) 10724-10734
23. Lambert P.F. Papillomavirus DNA replication. J. Virol. 65 (1991) 3417-3420
24. Lambert P.F., Baker C.C., and Howley P.M. The genetics of bovine papillomavirus type 1. Annu. Rev. Genet. 22 (1988) 235-258
25. Lambert P.F., Monk B.C., and Howley P.M. Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants. J. Virol. 64 (1990) 950-956
26. Lancaster W.D. Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells. Virology 108 (1981) 251-255
27. Law M.F., Lowy D.R., Dvoretzky I., and Howley P.M. Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 2727-2731
28. Linz U., and Baker C.C. Promoters of bovine papillomavirus type 1: in vitro activity and utilization. J. Virol. 62 (1988) 2537-2543
29. Lowy D.R., Dvoretzky I., Shober R., Law M.F., Engel L., and Howley P.M. In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA. Nature 287 (1980) 72-74
30. Meyers C., Frattini M.G., Hudson J.B., and Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257 (1992) 971-973
31. Morgan I.M., Grindlay G.J., and Campo M.S. The bovine papillomavirus type 4 long control region contains an epithelial specific enhancer. J. Gen. Virol. 80 (1999) 23-27
32. Müller M., Gissmann L., Cristiano R.J., Sun X.Y., Frazer I.H., Jenson A.B., Alonso A., Zentgraf H., and Zhou J. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69 (1995) 948-954
33. Ozbun M.A., and Meyers C. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J. Virol. 72 (1998) 2715-2722
34. Rando R.F., Lancaster W.D., Han P., and Lopez C. The noncoding region of HPV-6vc contains two distinct transcriptional enhancing elements. Virology 155 (1986) 545-556
35. Riese D., Settleman J., Neary K., and DiMaio D. Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity. J. Virol. 64 (1990) 944-949
36. Roden R.B.S., Kirnbauer R., Jenson A.B., Lowy D.R., and Schiller J.T. Interaction of papillomaviruses with the cell surface. J. Virol. 68 (1994) 7260-17266
37. Sanchez I.E., Dellarole M., Gaston K., and de Prat Gay G. Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res. 36 3 (2008) 756-769
38. Sandler A.B., Baker C.C., and Spalholz B.A. Sp1 is critical for basal and E2-transactivated transcription from the bovine papillomavirus type 1 P89 promoter. J. Gen. Virol. 77 (1996) 189-198
39. Schmid E., Schiller D.L., Grund C., Stadler J., and Franke W.W. Tissue type-specific expression of intermediate filament proteins in a cultured epithelial cell line from bovine mammary gland. J. Cell Biol. 96 (1983) 37-50
40. Spalholz B.A., Lambert P.F., Yee C.L., and Howley P.M. Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region. J. Virol. 61 (1987) 2128-2137
41. Spalholz B.A., Vande Pol S.B., and Howley P.M. Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter. J. Virol. 65 (1991) 743-753
42. Steger G., Ham J., and Yaniv M. E2 proteins: modulators of papillomavirus transcription and replication. Methods Enzymol. 274 (1996) 173-185
43. Stenlund A., and Botchan M.R. The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes Dev. 4 (1990) 123-136
44. Stenlund A., Bream G.L., and Botchan M.R. A promoter with an internal regulatory domain is part of the origin of replication in BPV-1. Science 236 (1987) 1666-1671
45. Stenlund A., Zabielski J., Ahola H., Moreno Lopez J., and Pettersson U. Messenger RNAs from the transforming region of bovine papilloma virus type I. J. Mol. Biol. 182 (1985) 541-554
46. Stubenrauch F., Lim H.B., and Laimins L.A. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J. Virol. 72 (1998) 1071-1077
47. Swift F.V., Bhat K., Younghusband H.B., and Hamada H. Characterization of a cell type-specific enhancer found in the human papilloma virus type 18 genome. EMBO J. 6 (1987) 1339-1344
48. Szymanski P., and Stenlund A. Regulation of early gene expression from the bovine papillomavirus genome in transiently transfected C127 cells. J. Virol. 65 (1991) 5710-5720
49. Thierry F., and Yaniv M. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J. 6 (1987) 3391-3397
50. Turek L.P., and Smith E.M. The genetic program of genital human papillomaviruses in infection and cancer. [Review] [151 refs]. Obstet. Gynecol. Clin. North Am. 23 (1996) 735-758
51. Turek L.P., Byrne J.C., Lowy D.R., Dvoretzky I., Friedman R.M., and Howley P.M. Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc. Natl. Acad. Sci. U. S. A. 79 (1982) 7914-7918
52. Turek, L.P., Haugen, T.H., Syrjanen, K., Gissmann, L., and Koss, L., (1987). In "Transforming and regulatory functions of bovine papillomavirus type 1", pp. 409-442. Springer, Heidelberg New York Tokyo.
53. Ushikai M., Lace M.J., Yamakawa Y., Kono M., Anson J., Ishiji T., Parkkinen S., Wicker N., Valentine M.E., Davidson I., Turek L.P., and Haugen T.H. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. J. Virol. 68 (1994) 6655-6666
54. Ustav M., and Stenlund A. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10 (1991) 449-457
55. Vance K.W., Campo M.S., and Morgan M. An enhanced epithelial response of a papillomavirus promoter to transcriptional activators. J. Biol. Chem. 274 (1999) 27839-27844
56. Vande Pol S.B., and Howley P.M. A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor. J. Virol. 64 (1990) 5420-5429
57. Vande Pol S.B., and Howley P.M. The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency. J. Virol. 66 (1992) 2346-2358
58. Volpers C., Unckell F., Schirmacher P., Streeck R.E., and Sapp M. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J. Virol. 69 (1995) 3258-3264
59. Xiao J.H., Davidson I., Matthes H., Garnier J.M., and Chambon P. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65 (1991) 551-568